When does NYMOX PHARMACEUTICAL CORP (NYMX) report earnings?
NYMOX PHARMACEUTICAL CORP (NYMX) will report earnings on 2023-08-15.
NYMOX PHARMACEUTICAL CORP (NYMX) Forecast, Price Target & Analyst Ratings
NASDAQ:NYMX • BSP733981026
Current stock price
0.2 USD
-0.05 (-19.68%)
At close:
0.1767 USD
-0.02 (-11.65%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NYMOX PHARMACEUTICAL CORP (NYMX).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $0.20 to mean target of $0.00, Based on 0 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 15, 2023
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 300K 36.36% | 120K -60.00% | 10K -91.67% | N/A -100.00% | N/A | |
| EBITDA YoY % growth | -10.64M 19.64% | -13.32M -25.19% | -11.71M 12.09% | N/A -6.68% | N/A 46.85% | |
| EBIT YoY % growth | -10.64M 19.64% | -13.33M -25.28% | -11.72M 12.08% | N/A -6.69% | N/A 46.80% | |
| Operating Margin | -3,546.67% | -11,108.33% | -117,200.00% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A